Reportstack

Eurocor GmbH - Product Pipeline Analysis, 2014 Update

 

Naperville, IL -- (ReleaseWire) -- 07/28/2014 -- Reportstack, provider of premium market research reports announces the addition of Eurocor GmbH - Product Pipeline Analysis, 2014 Update market report to its offering

Summary

Eurocor GmbH (Eurocor) is a life science technology company. The company operates with the research, development and manufacture of cardiovascular and endovascular products. It offer products, such as DIOR PTCA catheter, Magical drug-eluting stent system, Genius Magic coronary stent system, Genius Taxcor I coronary stent system, Amadeus SuperCross coronary dilatation catheter, Freeway 014 paclitaxel eluting peripheral dilatation catheter, freeway 035 paclitaxel, Joker 014 OTW PTA balloon catheter, and Joker 035 OTW balloons. Eurocor has its presence in Singapore, Malaysia and Poland. The company markets its products through distributors in Europe, Asia, Africa and America. It is a subsidiary of Opto Eurocor Healthcare Limited, a part of the Opto Circuits Group. Eurocor is headquartered in Bonn, Germany.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Eurocor GmbH
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Companies Mentioned

Eurocor GmbH

To view the table of contents for this market research report please visit
http://www.reportstack.com/product/164611/eurocor-gmbh-product-pipeline-analysis-2014-update.html

contactus@reportstack.com
Naperville
Illinois
United States
Ph: 888-789-6604